Your browser doesn't support javascript.
[Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant].
Du, M; Liu, M; Liu, J.
  • Du M; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
  • Liu M; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
  • Liu J; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 42(10): 1774-1779, 2021 Oct 10.
Article in Chinese | MEDLINE | ID: covidwho-1534279
ABSTRACT
SARS-CoV-2 Delta variant has the characteristics of stronger infectivity, higher viral load, and shorter incubation period, posing new challenges to the prevention and control of COVID-19 pandemic. SARS-CoV-2 Delta variant was first discovered in India, then quickly spread in many countries and has gradually become one of the main epidemic strains worldwide. Local epidemics caused by SARS-CoV-2 Delta variant also occurred in several provinces in China. This article summarizes the progress in research of etiological characteristics, transmission characteristics or possible mechanism and epidemiological characteristics of SARS-CoV-2 Delta variant, and the protective effects of vaccines and control measures against SARS-CoV-2 Delta variant in order to provide references for the effective prevention and control of COVID-19 epidemic caused by SARS-CoV-2 Delta variant.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology study / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Asia Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2021 Document Type: Article Affiliation country: Cma.j.cn112338-20210808-00619

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology study / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Asia Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2021 Document Type: Article Affiliation country: Cma.j.cn112338-20210808-00619